D-0597-2024 Class II Terminated

Recalled by SUN PHARMACEUTICAL INDUSTRIES INC — Princeton, NJ

FDA drug recall D-0597-2024 was initiated by SUN PHARMACEUTICAL INDUSTRIES INC on Jul 9, 2024 and is designated Class II. Reason for recall: Failed Dissolution Specifications The recall status is terminated (terminated Dec 22, 2025). Affected quantity: 5752 bottles.

Recall Details

Product Type
Drugs
Report Date
Jul 24, 2024
Initiation Date
Jul 9, 2024
Termination Date
Dec 22, 2025
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
5752 bottles

Product Description

Nitrofurantoin Capsules, USP (Macrocrystals), 100 mg, Rx Only, 100 capsules per bottle, Manufactured by: Sidmak Laboratories (India) Pvt. Ltd. Plot No. 20, Pharmacity, Selaqui Industrial Area, Dehradun - 248-197, Uttarakhand, India. Distributed by: Sun Pharmaceutical Industries, Inc. Cranbury, NJ 08512, NDC 57664-233-88.

Reason for Recall

Failed Dissolution Specifications

Distribution Pattern

Nationwide in the USA and Puerto rico

Code Information

Lot #s: 231067, 231069, Exp 04/30/2025

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-0597-2024
openFDA file date
Oct 23, 2026
Loaded by RegDataLab
Oct 26, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.